S&P 500$7,553.68
-0.74%
2m
DOW 30$50,687.07
-1.21%
2m
NASDAQ 100$30,571.24
-0.29%
2m
Russell 2000$287.67
-1.37%
2m
Russell 1000$411.83
-0.71%
2m
S&P 400$3,751.11
-0.10%
2m
S&P 600$1,681.95
-0.85%
2m

QUANTERIX (QTRX)

NASDAQ

$3.47-$0.06 (-1.84%)

Price as of Jun 03, 2026 5:57 PM EDT

$144.1M
Market Cap
-36.74%
1-Year Change
Medical Devices
Industry

Annual

Quarterly

	12/31/2025	12/31/2024	12/31/2023	12/31/2022
Income Statement
Total Operating Revenue	92.9M -32.37%	137.4M +12.30%	122.4M +15.96%	105.5M -4.55%
Cost of Revenue	51.0M -6.14%	54.3M +12.82%	48.1M -18.01%	58.7M +20.25%
Gross Profit	65.0M -21.83%	83.1M +11.96%	74.2M +58.58%	46.8M -24.17%
Sales and Marketing Expense	138.0M +35.81%	101.6M +14.04%	89.1M -3.13%	92.0M -0.37%
Research and Development Expense	-35.9M +15.57%	-31.1M +19.25%	-26.1M +0.67%	-25.9M -7.46%
Depreciation and Amortization Expense	15.8M +145.15%	6.5M +3.00%	6.3M +17.31%	5.3M +10.27%
Total Operating Expenses	190.5M +40.36%	135.7M +12.90%	120.2M -19.05%	148.5M +23.44%
Operating Profit	-125.5M +138.60%	-52.6M +14.40%	-46.0M -54.78%	-101.7M +73.60%
Interest Income	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Interest Expense	N/A N/A	N/A N/A	0 N/A	N/A N/A
Interest Income and Expense and Net	0 N/A	0 N/A	0 N/A	0 +100.00%
Total Nonoperating Income and Expense	157,000 +215.44%	-136,000 -105.40%	2.5M +4,159.68%	-62,000 -104.90%
Income before Taxes	-112.3M +194.70%	-38.1M +37.86%	-27.6M -71.40%	-96.6M +67.41%
Income Taxes	-5.1M -1,279.95%	434,000 -39.64%	719,000 +1,006.15%	65,000 +280.56%
Extraordinary Items	7.8M N/A	0 -100.00%	1.4M N/A	N/A N/A
Net Income	-107.2M +178.09%	-38.5M +35.89%	-28.4M -70.68%	-96.7M +67.63%
Net Income from Continuing Operations Applicable to Common	-112.3M +194.70%	-38.1M +37.86%	-27.6M -71.40%	-96.6M +67.41%
Basic EPS and Net Income	-2.51 +151.00%	-1.00 +33.33%	-0.75 -71.26%	-2.61 +63.13%
Diluted EPS and Net Income	-2.51 +151.00%	-1.00 +33.33%	-0.75 -71.26%	-2.61 +63.13%
Basic Weighted Average Shares	42.6M +11.13%	38.4M +2.06%	37.6M +1.63%	37.0M +2.76%
Diluted Weighted Average Shares	42.6M +11.13%	38.4M +2.06%	37.6M +1.63%	37.0M +2.76%
Balance Sheet
Cash and Cash Equivalents	29.8M -47.38%	56.7M -67.49%	174.4M -48.51%	338.7M -14.56%
Short-Term Investments	88.4M -61.97%	232.4M +58.21%	146.9M N/A	N/A N/A
Cash and Cash Equivalents and Short-Term Investments	118.2M -59.11%	289.1M -10.02%	321.3M -5.14%	338.7M -14.56%
Total Current Assets	212.3M -41.62%	363.6M -4.84%	382.1M +0.18%	381.4M -15.05%
Accumulated Depreciation	25.8M +37.20%	18.8M +33.31%	14.1M +28.83%	11.0M +42.26%
Property and Plant and Equipment and Net	23.7M +38.03%	17.1M -4.33%	17.9M -11.09%	20.2M +12.26%
Total Long-Term Assets	4.7M +66.22%	2.8M +69.52%	1.7M +27.66%	1.3M +243.39%
Total Assets	418.8M +3.01%	406.5M -5.14%	428.6M -1.30%	434.2M -13.42%
Income Taxes Payable	1.1M +10.51%	1.0M +23.84%	822,000 +377.91%	172,000 -91.55%
Total Short-Term Debt	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Total Current Liabilities	74.8M +77.98%	42.0M +7.76%	39.0M +25.92%	31.0M -16.28%
Total Long-Term Debt	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Total Long-Term Liabilities	8.1M +912.13%	800,000 -32.03%	1.2M -19.88%	1.5M -94.27%
Total Liabilities	123.0M +60.84%	76.5M -2.69%	78.6M +4.45%	75.3M +24.24%
Retained Earnings	-577.2M +22.79%	-470.1M +8.93%	-431.6M +7.31%	-402.2M +31.66%
Total Stockholders Equity	295.7M -10.40%	330.0M -5.69%	350.0M -2.50%	358.9M -18.60%
Total Shares Outstanding	46.7M +21.27%	38.5M +1.39%	38.0M +1.97%	37.3M +1.39%
Cash Flow
Cash from Operating Activities	-77.2M +119.65%	-35.2M +86.56%	-18.8M -60.95%	-48.3M +0.76%
Capital Expenditures	2.6M -22.45%	3.4M -12.31%	3.8M -67.24%	11.7M -13.88%
Cash from Investing Activities	50.2M +161.06%	-82.3M -44.59%	-148.5M +1,224.77%	-11.2M +76.81%
Dividends Paid	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Cash from Financing Activities	-708,000 -255.26%	456,000 -83.05%	2.7M +16.44%	2.3M -99.15%
Financials Ratio
Gross Margin	45.15% -25.34%	60.47% -0.30%	60.66% +36.75%	44.36% -20.56%
Operating Margin	-135.08% +252.79%	-38.29% +1.87%	-37.58% -61.00%	-96.38% +81.88%
Return on Assets	-25.97% +181.39%	-9.23% +40.40%	-6.57% -68.20%	-20.67% +38.40%
Return on Equity	-34.25% +202.19%	-11.33% +41.67%	-8.00% -66.91%	-24.18% +35.60%
Revenue Growth	-32.37% -363.12%	12.30% -22.94%	15.96% +450.61%	-4.55% -116.27%
Current Ratio	2.84 -67.20%	8.66 -11.69%	9.80 -20.44%	12.32 +1.47%
Cash Ratio	0.40 -70.44%	1.35 -69.83%	4.47 -59.11%	10.94 +2.05%
Debt-to-Equity Ratio	N/A N/A	N/A N/A	N/A N/A	N/A N/A
Debt-to-Assets Ratio	N/A N/A	N/A N/A	N/A N/A	N/A N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow